Terms ending in 2038
Every in-force patent on BGI Shenzhen's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,121,549 | Application of Alistipes shahii in preparing a composition for preventing and/or treating lipid metabolism related diseases In force · High confidence | BGI Shenzhen | In force | High confidence | |
| US 11,788,138 | Nucleic Acid Sequencing Using Affinity Reagents In force · High confidence | Mgi Tech Co., Ltd. | In force | High confidence | |
| US 11,376,289 | Composition and uses thereof In force · High confidence | BGI Shenzhen | In force | High confidence | |
| US 10,851,410 | Nucleic Acid Sequencing Using Affinity Reagents In force · High confidence | Mgi Tech Co., Ltd. | In force | High confidence | |
| US 12,104,203 | Method for Constructing Library of Cell-Free DNAs in Body Fluids and Application Thereof In force · High confidence | BGI Shenzhen | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by BGI Shenzhen.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.